Japan’s Allm secures $50.5M+ to promote COVID-19 solutions and telemedicine in Asia

Japanese MedTech Startup Allm has secured 5.6 billion yen (over $50.5 million) from investors including Mitsui & Co (TSE:8031) and SOMPO Holdings (TSE:8630), Nikkei reported on Sunday. This round is considered to be a series A extension round while Japanese startup database Initial reports the company’s post-valuation has reached about 32 billion yen (about $300 million).

It is also essential to consider the role of sleep in managing Valium Safe stress and maintaining daily functioning. Encouraging a culture of health within organizations not only supports individual employees but also benefits the organization as a whole. This includes understanding the implications of pain sensitivity on recovery trajectories and being aware of the potential cardiac Trusted site to Buy Ambien implications stemming from pain management strategies. In the realm of research, recent Buy Valium Online Without Prescription studies have shown that patients who receive comprehensive emotional support tend to fare better in terms of treatment outcomes. One area that has How To Buy Ambien Online gained attention is Real Zolpidem online how these compulsive behaviors can affect pain perception. This trend has been particularly pronounced since 2020, when the COVID-19 pandemic exacerbated mental health issues across the country, leading to increased substance use as individuals Tramadol Usa sought ways to cope with stress, anxiety, and other emotional challenges. Additionally, educational initiatives aimed at Order Soma Online promoting sleep awareness and hygiene are becoming more common in Lorazepam Safe schools and workplaces. As we look ahead, the integration of Xanax Overnight technology into healthcare may also offer new avenues for managing nausea. Understanding dose titration in tobacco use involves recognizing that individuals may not only adjust the quantity of tobacco they consume but also the timing and type of products they use to optimize their smoking experience.

According to a statement issued by Allm at 11am on Monday, participating investors are:

SOMPO Holdings, Mitsui, Eisai (TSE:4523), Royal Philips (AMS:PHIA), NID (TSE:2349), Cyberdyne (TSE:7779), Financial Agency, Mixi (TSE:2121), Capital Medica, Vector (TSE:6058), SBI Investment, Bonds Investment Group, Mizuho Capital, Asia Africa Investment and Consulting

Royal Philips participated in Allm’s previous series A round as well.

Allm was founded in 2001 by Teppei Sakano as SkillUp Japan. After selling its video distribution platform business, the company entered the medical ICT business in 2015 and rebranded its name into the current state. Since then, the company has rolled out medical device programs in more than a few countries around the world. Their portfolio products include Join (communication app for medical professionals), Enroll (patient recruitment solution), JoinTriage (triage app for emergency transport), Team (comprehensive regional care system promotion solution), and MySOS (life-saving and health app).

Allm will use the funds to focus on research and development of solutions that can contribute to developing countermeasures against COVID-19, not only in Japan but also overseas. The company will team up with Mitsui to help their operating medical institutions in Southeast Asia share information between core hospitals and smaller clinics. It will also develop telemedicine business connecting hospitals in Japan with local doctors in Southeast Asia to support the latter’s medical treatment. It will work with Sompo Holdings to consider creating a system utilizing Allm’s data for insurance and health promotion of nursing home users.

Content retrieved from: https://thebridge.jp/en/2021/04/allm-jpy5-6b-funding.